Apr 19 |
Cancer test maker Dermtech to cut 100 jobs, explore strategic options
|
Apr 18 |
DermTech exploring strategic alternatives, cutting 56% of staff
|
Apr 18 |
DermTech to Explore Strategic Alternatives and Implement Restructuring Plan
|
Apr 1 |
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Mar 8 |
DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
|
Mar 3 |
DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know
|
Mar 2 |
DermTech, Inc. (NASDAQ:DMTK) Q4 2023 Earnings Call Transcript
|
Mar 1 |
DermTech, Inc. (DMTK) Q4 2023 Earnings Call Transcript
|
Feb 29 |
DermTech, Inc. (DMTK) Reports Q4 Loss, Misses Revenue Estimates
|
Feb 29 |
DermTech GAAP EPS of -$0.56 in-line, revenue of $3.92M misses by $0.11M
|